October 18, 2017. The USPSTF proposes a plan to review research and evidence on the benefits and harms of Hepatitis C virus screening in adults and adolescents. Our Center supports the efforts of USPSTF to reassess the merits of broad screening programs. We offer additional suggestions for an analysis plan that will inform future recommendations and best practice guidelines on this most important issue.
Read More »Author: Caroline Bradford
NCHR Comments on the USPSTF Draft Research Plan for Asymptomatic Bacteriuria in Adults: Screening
Not all bacteria is bad, and we don’t have to treat everything we detect. We urge the USPSTF to consider the new evidence for or against broad screening.
Read More »NCHR Comments on the USPSTF’s Draft Recommendation Statement, Evidence Review, and Modeling Report on Cervical Cancer Screening
October 9, 2017. The USPSTF proposes new cervical cancer screening recommendations. Surprisingly, the USPSTF proposes eliminating co-testing (pap and HPV test together) as a preferred screening approach in favor of the HPV test alone. Do the proposed recommendations deserve an “A” rating? Read our comments to find out.
Read More »NCHR Comment on the USPSTF’s Draft Recommendations for Hepatitis B Virus Infection Screening in Pregnant Women
August 9, 2017. We support the USPSTF’s draft recommendation for Hepatitis B screening in pregnant women. Universal screening and prevention programs for pregnant women with Hepatitis B can help to identify pregnant women who are at risk for passing the virus to their children. Preventing vertical transmission protects children from a potentially serious disease and other diseases that may develop as a result, such as cancer; protects others who may be infected; and allows children to participate in school and play activities important to their healthy development. Therefore, screening is highly beneficial for these children.
Read More »NCHR Comment on the USPSTF’s Draft Recommendations for Breast Cancer: Medications for Risk Reduction
April 19, 2017. We support the USPSTF’s efforts to re-evaluate recommendations as the scientific evidence expands and improves. In addition, we strongly urge the USPSTF to consider how the apparently modest benefits of medications compare to specific lifestyle changes for reducing breast cancer risk.
Read More »